hyaluronoglucosaminidase has been researched along with 2019 Novel Coronavirus Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bi, Y; Chen, W; Hu, W; Li, J; Liu, J; Shi, D; Xiang, Z; Yan, R; Yang, Z; Yu, Y; Zhu, Z | 1 |
López Pérez, V | 1 |
Beswick, EJ; Campbell, RA; Denorme, F; Manne, BK; Mellema, RA; Middleton, EA; Petrey, AC; Portier, I; Queisser, KA; Rondina, MT | 1 |
1 review(s) available for hyaluronoglucosaminidase and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
COVID-19 and Dermal Fillers: Should We Really Be Concerned?
Topics: Anti-Bacterial Agents; COVID-19; Dermal Fillers; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; SARS-CoV-2 | 2022 |
2 other study(ies) available for hyaluronoglucosaminidase and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels.
Topics: Adenosine; Adult; Aged; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Cell Line; Cell Line, Tumor; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Epithelial Cells; Female; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Hydrocortisone; Interleukin-6; Kinetin; Macrophages; Male; Middle Aged; Monocytes; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Retrospective Studies; Ribonucleosides; SARS-CoV-2; Transcriptome | 2020 |
COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction.
Topics: Aged; COVID-19; Cytokines; Endothelium, Vascular; Female; Glycocalyx; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Middle Aged; rho-Associated Kinases | 2021 |